SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Everest Organics files first US DMF

04 Sep 2019 Evaluate

Everest Organics has submitted the first US DMF for Esomeprazole Magnesium API.

Ever since the successful USFDA approval received for its manufacturing facility, the company has placed a separate focus to strengthen its presence in regulatory markets. With the first filing of US-DMF for Esomeprazole Magnesium, the company focuses to increase presence in the US market for substantial revenue generation.

Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and it is committed to manufacturing excellent quality products and customer service.

Everest Organics Share Price

267.75 17.65 (7.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×